iA Global Asset Management Inc.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1969566
Quebec, A8
Position in TEVA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$11,574,153
+$2,567,219 QoQ
Shares Held
341,622
+14.2% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#142
of 675 holders
Holding Since
Mar 2024
10 quarters on record
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $25,098,205 across 5 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
341,622 | $11,574,153 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
303,786 | $5,455,996 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
522,992 | $5,141,011 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,166 | $1,544,837 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,551 | $1,382,208 |
All Filings in TEVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,574,153 | 341,622 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $9,006,934 | 299,035 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,491,960 | 208,009 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,215,921 | 208,709 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $3,194,606 | 190,609 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,987,005 | 194,340 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $7,826,822 | 355,119 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,944,855 | 440,891 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $6,809,968 | 419,075 | Shares | Sole | 2025-04-08 | |
| 2024-03-31 | $1,489,169 | 105,540 | Shares | Sole | 2025-04-08 | |
| No filing history on record for this holder in this stock. | ||||||